Tocilizumab in Patients with Covid-19 Pneumonia


Next in Epidemiology

Carlos Salama discusses how hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation and received tocilizumab showed a reduction in the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival.

Image courtesy of Carlos Salama

Image courtesy of interviewee. March 12, 2021

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month. Login to view 8000+ figures on the platform.
Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.
error:
Skip to content